BRISTOL-MYERS SQUIBB NAMES STEPHEN BEAR TO HEAD WORLDWIDE OTC DRUG BUSINESS
This article was originally published in The Tan Sheet
Executive Summary
BRISTOL-MYERS SQUIBB NAMES STEPHEN BEAR TO HEAD WORLDWIDE OTC DRUG BUSINESS as part of a management reorganization of the company's international consumer products businesses. Formerly executive VP of Bristol-Myers Squibb's U.S. Consumer Products Group, Bear has been named president of Worldwide Consumer Medicines with responsibility for "the global activities" of the Bristol-Myers Products Division and the company's consumer businesses in Japan, the company said. Bear, 42, will report directly to Bristol-Myers Squibb President and CEO Charles Heimbold.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: